CN115198006A - An XNA molecular clamp-multiplex fluorescent PCR method for gene mutation detection - Google Patents
An XNA molecular clamp-multiplex fluorescent PCR method for gene mutation detection Download PDFInfo
- Publication number
- CN115198006A CN115198006A CN202210854682.7A CN202210854682A CN115198006A CN 115198006 A CN115198006 A CN 115198006A CN 202210854682 A CN202210854682 A CN 202210854682A CN 115198006 A CN115198006 A CN 115198006A
- Authority
- CN
- China
- Prior art keywords
- sample
- gene mutation
- crna
- rna
- detected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 27
- 206010064571 Gene mutation Diseases 0.000 title claims abstract description 25
- 238000001514 detection method Methods 0.000 title claims abstract description 21
- 238000009792 diffusion process Methods 0.000 claims abstract description 12
- 238000003752 polymerase chain reaction Methods 0.000 claims description 15
- 230000003321 amplification Effects 0.000 claims description 10
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 230000001105 regulatory effect Effects 0.000 claims description 7
- 238000010839 reverse transcription Methods 0.000 claims description 6
- 239000001963 growth medium Substances 0.000 claims description 5
- 238000012408 PCR amplification Methods 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 102100034343 Integrase Human genes 0.000 claims description 3
- 208000019693 Lung disease Diseases 0.000 claims description 3
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 3
- 238000000137 annealing Methods 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 238000004925 denaturation Methods 0.000 claims description 3
- 230000036425 denaturation Effects 0.000 claims description 3
- 239000002504 physiological saline solution Substances 0.000 claims description 3
- 238000012257 pre-denaturation Methods 0.000 claims description 3
- 210000003296 saliva Anatomy 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 210000003608 fece Anatomy 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 239000000523 sample Substances 0.000 abstract description 30
- 230000004927 fusion Effects 0.000 abstract description 4
- 108090000623 proteins and genes Proteins 0.000 abstract description 4
- 238000003753 real-time PCR Methods 0.000 abstract description 3
- 244000005700 microbiome Species 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 17
- 238000012360 testing method Methods 0.000 description 8
- 239000000284 extract Substances 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 3
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 230000036438 mutation frequency Effects 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 102100033793 ALK tyrosine kinase receptor Human genes 0.000 description 1
- 102100035080 BDNF/NT-3 growth factors receptor Human genes 0.000 description 1
- 102100030708 GTPase KRas Human genes 0.000 description 1
- 102100035108 High affinity nerve growth factor receptor Human genes 0.000 description 1
- 101000779641 Homo sapiens ALK tyrosine kinase receptor Proteins 0.000 description 1
- 101000596896 Homo sapiens BDNF/NT-3 growth factors receptor Proteins 0.000 description 1
- 101000584612 Homo sapiens GTPase KRas Proteins 0.000 description 1
- 101000596894 Homo sapiens High affinity nerve growth factor receptor Proteins 0.000 description 1
- 101000686031 Homo sapiens Proto-oncogene tyrosine-protein kinase ROS Proteins 0.000 description 1
- 101000579425 Homo sapiens Proto-oncogene tyrosine-protein kinase receptor Ret Proteins 0.000 description 1
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 101100508818 Mus musculus Inpp5k gene Proteins 0.000 description 1
- 101150117329 NTRK3 gene Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 102100023347 Proto-oncogene tyrosine-protein kinase ROS Human genes 0.000 description 1
- 102100028286 Proto-oncogene tyrosine-protein kinase receptor Ret Human genes 0.000 description 1
- 101100366438 Rattus norvegicus Sphkap gene Proteins 0.000 description 1
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 101150048834 braF gene Proteins 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000000110 cooling liquid Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 1
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011528 liquid biopsy Methods 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 1
- 238000002626 targeted therapy Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明涉及微生物技术领域,具体涉及一种XNA分子钳‑多重荧光PCR法基因突变检测方法;包括制备待测样品;提取所述待测样品中的DNA和RNA,并将所述RNA逆转处理,得到cRNA,再将所述cRNA和所述DNA混合后进行多重荧光PCR扩散,得到荧光样品;通过荧光PCR扩增仪检测所述荧光样品,并显示所述荧光样品的ct值判定检测结果,该方法引入多重荧光PCR扩散技术,通过采用特异性引物和探针技术,三色荧光通道检测模式,建立了实时PCR体系,可以同时检测多种融合基因和多种突变基因,具备特异性好,准确率高,快速廉价,解决现有试剂盒对基因突变状态进行检测耗时长的问题。
The invention relates to the technical field of microorganisms, in particular to an XNA molecular clamp-multiplex fluorescence PCR method for gene mutation detection; comprising preparing a sample to be tested; extracting DNA and RNA in the sample to be tested, and reversing the RNA, The cRNA is obtained, and then the cRNA and the DNA are mixed and subjected to multiple fluorescent PCR diffusion to obtain a fluorescent sample; the fluorescent sample is detected by a fluorescent PCR amplifier, and the ct value of the fluorescent sample is displayed to determine the detection result. Methods The multiplex fluorescence PCR diffusion technology was introduced, and the real-time PCR system was established by using specific primer and probe technology and three-color fluorescence channel detection mode, which could detect multiple fusion genes and multiple mutant genes at the same time, with good specificity and accuracy. It has high rate, fast and cheap, and solves the problem of time-consuming detection of gene mutation status by existing kits.
Description
技术领域technical field
本发明涉及微生物技术领域,尤其涉及一种XNA分子钳-多重荧光PCR法基因突变检测方法。The invention relates to the technical field of microorganisms, in particular to an XNA molecular clamp-multiplex fluorescence PCR method for gene mutation detection.
背景技术Background technique
肺癌是严重危害人类健康的常见恶性肿瘤之一,其中80~85%的肺癌为非小细胞肺癌。非小细胞肺癌患者中存在多种基因突变类型,其中EGFR、HER2、KRAS、BRAF基因突变频率分别约为10~50%、1~4%、5~25%、1~2%,ALK、ROS1、RET、NTRK1、NTRK2、NTRK3基因融合发生频率分别约为3~7%、1%、1%、0.12%、0.02%、0.08%,MET外显子14跳跃基因突变发生频率约为1%。大量临床研究表明,驱动基因突变状态是靶向药物治疗的重要疗效预测因子,在进行靶向治疗前需要对基因突变状态进行检测,并强烈建议进行更广泛的有效基因的状态检测,因此,对非小细胞肺癌患者的多基因突变联合检测可为患者提供更精准的治疗。Lung cancer is one of the common malignant tumors that seriously endanger human health, and 80-85% of lung cancers are non-small cell lung cancers. There are various types of gene mutation in patients with non-small cell lung cancer, among which the mutation frequency of EGFR, HER2, KRAS, BRAF gene is about 10-50%, 1-4%, 5-25%, 1-2%, ALK, ROS1 , RET, NTRK1, NTRK2, NTRK3 gene fusion frequency is about 3-7%, 1%, 1%, 0.12%, 0.02%, 0.08%, MET exon 14 skip gene mutation frequency is about 1%. A large number of clinical studies have shown that the driver gene mutation status is an important predictor of the efficacy of targeted drug therapy, and it is necessary to detect the gene mutation status before targeted therapy. Combined detection of multiple gene mutations in patients with non-small cell lung cancer can provide patients with more precise treatment.
XNA分子钳是一种新型的核酸分子低聚体,与靶DNA序列杂交,可作为实时定量聚合酶链反应中的分子钳,XNA分子钳检测可以使用液体活检和FFPE样本产生高灵敏度的结果。XNA molecular clamp is a novel nucleic acid molecule oligomer that hybridizes to target DNA sequences and can be used as a molecular clamp in real-time quantitative polymerase chain reaction. The XNA molecular clamp assay can produce highly sensitive results using liquid biopsy and FFPE samples.
这些基因突变或融合状态与靶向药物的疗效相关,然而,目前大多数试剂盒每次只能检测一种或几种基因突变,检测通量低,耗时长,对样本需求量大。These gene mutations or fusion states are related to the efficacy of targeted drugs. However, most of the current kits can only detect one or several gene mutations at a time. The detection throughput is low, time-consuming and requires a large amount of samples.
发明内容SUMMARY OF THE INVENTION
本发明的目的在于提供一种XNA分子钳-多重荧光PCR法基因突变检测方法,解决现有试剂盒对基因突变状态进行检测耗时长的问题。The purpose of the present invention is to provide an XNA molecular clamp-multiplex fluorescent PCR method for gene mutation detection method, which solves the problem that the detection of gene mutation status takes a long time in the existing kits.
为实现上述目的,本发明提供了一种XNA分子钳-多重荧光PCR法基因突变检测方法:To achieve the above purpose, the present invention provides an XNA molecular clamp-multiplex fluorescent PCR method for gene mutation detection:
制备待测样品;prepare samples to be tested;
提取所述待测样品中的DNA和RNA,并将所述RNA逆转处理,得到cRNA,再将所述cRNA和所述DNA混合后进行多重荧光PCR扩散,得到荧光样品;Extracting the DNA and RNA in the sample to be tested, and reversing the RNA to obtain cRNA, then mixing the cRNA and the DNA and performing multiple fluorescence PCR diffusion to obtain a fluorescent sample;
通过荧光PCR扩增仪检测所述荧光样品,并显示所述荧光样品的ct值判定检测结果。The fluorescent sample is detected by a fluorescent PCR amplifier, and the ct value of the fluorescent sample is displayed to determine the detection result.
其中,所述制备待测样品的具体方式:Wherein, the specific way of preparing the sample to be tested:
将各个来源于无肺病病史健康人群唾液与粪便样本均接种于培养基中,37℃静置厌氧培养20-40h;All saliva and fecal samples from healthy people with no history of lung disease were inoculated into the culture medium, and cultured at 37°C for 20-40h anaerobic;
分别取各个所述培养基中的培养液4ml进行离心,5500rpm,10min,离心后的菌体用pH为6.8的无菌生理盐水洗涤,洗涤后再次进行离心,5500rpm,10min,得到无菌纯水悬浮菌体;Take 4ml of the culture solution in each of the culture medium and centrifuge, 5500rpm, 10min, the thalline after centrifugation is washed with sterile physiological saline with pH 6.8, and centrifuge again after washing, 5500rpm, 10min to obtain sterile pure water suspended bacteria;
将400uL的所述无菌纯水悬浮菌体,沸水浴10min,10000rpm离心15min,收集上清液。Suspend the bacterial cells in 400 uL of the sterile pure water, take a boiling water bath for 10 minutes, centrifuge at 10,000 rpm for 15 minutes, and collect the supernatant.
其中,提取所述待测样品中的DNA和RNA,并将所述RNA逆转处理,得到cRNA,再将所述cRNA和所述DNA混合后进行多重荧光PCR扩散,得到荧光样品的具体方式:The specific method of extracting the DNA and RNA in the sample to be tested, and reversing the RNA to obtain cRNA, and then mixing the cRNA and the DNA to perform multiple fluorescence PCR diffusion to obtain a fluorescent sample:
提取所述待测样品中的DNA和RNA,往提取到的所述RNA加热入逆转录反应液,所述RNA与所述逆转录反应液中的逆转录酶混合,得到cRNA;Extracting DNA and RNA in the sample to be tested, heating the extracted RNA into a reverse transcription reaction solution, and mixing the RNA with the reverse transcriptase in the reverse transcription reaction solution to obtain cRNA;
将所述DNA和所述cRNA分别与混合酶混合,并对混合的所述DNA和所述cRNA进行多重荧光PCR扩散,得到所述荧光样品。The DNA and the cRNA are respectively mixed with a mixed enzyme, and the mixed DNA and the cRNA are subjected to multiplex fluorescence PCR diffusion to obtain the fluorescent sample.
其中,所述PCR扩增的反应条件为94℃预变性3min,94℃变性10S,55℃退火30S,72℃延伸90S,整个体系做28个循环,72℃后延伸5min。The reaction conditions of the PCR amplification were pre-denaturation at 94°C for 3 min, denaturation at 94°C for 10S, annealing at 55°C for 30S, extension at 72°C for 90S, the entire system was performed for 28 cycles, and extension at 72°C for 5 min.
其中,所述荧光PCR扩增仪包括壳体、扩增仪本体、调温板和放置组件,所述扩增仪本体与所述壳体固定连接,且位于所述壳体内,所述调温板设置于所述壳体内,所述放置组件设置于所述调温板远离所述扩增仪本体一侧。Wherein, the fluorescent PCR amplifier includes a casing, an amplifier body, a temperature regulation plate and a placement component, the amplifier body is fixedly connected to the casing, and is located in the casing, and the temperature regulation The plate is arranged in the casing, and the placing component is arranged on the side of the temperature regulation plate away from the body of the amplification instrument.
其中,所述放置组件包括放置板、顶杆、固定杆和滑块,所述顶杆设置于所述壳体靠近所述扩增仪本体一侧,所述放置板与所述壳体滑动连接,且位于所述壳体内,所述壳体具有卡槽,所述放置板具有滑槽,所述固定杆设置于所述滑槽内,所述滑块与所述固定杆固定连接,并贯穿所述放置板。Wherein, the placing assembly includes a placing plate, a push rod, a fixing rod and a slider, the push rod is disposed on the side of the casing close to the amplification instrument body, and the placing plate is slidably connected to the casing , and is located in the housing, the housing has a slot, the placement plate has a chute, the fixing rod is arranged in the chute, the slider is fixedly connected with the fixing rod, and penetrates through the the placement plate.
其中,所述固定杆包括滑杆和第一弹簧,所述滑杆与所述放置板滑动连接,且位于所述滑槽内,所述第一弹簧与所述滑杆固定连接,并与所述放置板固定连接,且位于所述滑杆和所述放置板之间。Wherein, the fixing rod includes a sliding rod and a first spring, the sliding rod is slidably connected with the placing plate and is located in the sliding groove, the first spring is fixedly connected with the sliding rod, and is connected with the The placing plate is fixedly connected and located between the sliding rod and the placing plate.
本发明的一种XNA分子钳-多重荧光PCR法基因突变检测方法,制备待测样品;提取所述待测样品中的DNA和RNA,并将所述RNA逆转处理,得到cRNA,再将所述cRNA和所述DNA混合后进行多重荧光PCR扩散,得到荧光样品;通过荧光PCR扩增仪检测所述荧光样品,并显示所述荧光样品的ct值判定检测结果,该方法引入多重荧光PCR扩散技术,通过采用特异性引物和探针技术,三色荧光通道检测模式,建立了实时PCR体系,可以同时检测多种融合基因和多种突变基因,具备特异性好,准确率高,快速廉价,解决现有试剂盒对基因突变状态进行检测耗时长的问题。A method for detecting gene mutation by XNA molecular clamp-multiplex fluorescence PCR method of the present invention prepares a sample to be tested; extracts DNA and RNA in the sample to be tested, and reverses the RNA to obtain cRNA, and then the After the cRNA and the DNA are mixed, multiplex fluorescent PCR diffusion is performed to obtain a fluorescent sample; the fluorescent sample is detected by a fluorescent PCR amplifier, and the ct value of the fluorescent sample is displayed to determine the detection result. This method introduces the multiple fluorescent PCR diffusion technology , By using specific primers and probe technology, three-color fluorescence channel detection mode, a real-time PCR system has been established, which can detect multiple fusion genes and multiple mutant genes at the same time, with good specificity, high accuracy, fast and cheap, and the solution The detection of gene mutation status by existing kits is time-consuming.
附图说明Description of drawings
为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to explain the embodiments of the present invention or the technical solutions in the prior art more clearly, the following briefly introduces the accompanying drawings that need to be used in the description of the embodiments or the prior art. Obviously, the accompanying drawings in the following description are only These are some embodiments of the present invention. For those of ordinary skill in the art, other drawings can also be obtained according to these drawings without creative efforts.
图1是本发明提供的一种XNA分子钳-多重荧光PCR法基因突变检测方法的流程图。FIG. 1 is a flow chart of a method for detecting gene mutation by XNA molecular clamp-multiplex fluorescence PCR method provided by the present invention.
图2是本发明提供的荧光PCR扩增仪的结构示意图。FIG. 2 is a schematic structural diagram of the fluorescence PCR amplifier provided by the present invention.
图3是本发明提供的荧光PCR扩增仪的的内部剖视图。FIG. 3 is an internal cross-sectional view of the fluorescence PCR amplifier provided by the present invention.
图中:1-壳体、2-卡槽、3-扩增仪本体、4-调温板、5-放置板、6-滑槽、7-滑杆、8-第一弹簧、9-滑块本体、10-拉杆、11-伸缩杆、12-第二弹簧。In the picture: 1-shell, 2-card slot, 3-amplifier body, 4-thermostat plate, 5-placement plate, 6-chute, 7-slide bar, 8-first spring, 9-slider Block body, 10-draw rod, 11- telescopic rod, 12-second spring.
具体实施方式Detailed ways
下面详细描述本发明的实施例,所述实施例的示例在附图中示出,其中自始至终相同或类似的标号表示相同或类似的元件或具有相同或类似功能的元件。下面通过参考附图描述的实施例是示例性的,旨在用于解释本发明,而不能理解为对本发明的限制。The following describes in detail the embodiments of the present invention, examples of which are illustrated in the accompanying drawings, wherein the same or similar reference numerals refer to the same or similar elements or elements having the same or similar functions throughout. The embodiments described below with reference to the accompanying drawings are exemplary, and are intended to explain the present invention and should not be construed as limiting the present invention.
请参阅图1至图3,本发明提供一种XNA分子钳-多重荧光PCR法基因突变检测方法,包括以下步骤:Please refer to FIG. 1 to FIG. 3 , the present invention provides an XNA molecular clamp-multiplex fluorescence PCR method for gene mutation detection, comprising the following steps:
S1制备待测样品;S1 prepares the sample to be tested;
具体方式:Specific way:
S11将各个来源于无肺病病史健康人群唾液与粪便样本均接种于培养基中,37℃静置厌氧培养20-40h;S11 Inoculate saliva and feces samples from healthy people with no history of lung disease into culture medium, and inoculate anaerobic culture at 37°C for 20-40h;
S12分别取各个所述培养基中的培养液4ml进行离心,5500rpm,10min,离心后的菌体用pH为6.8的无菌生理盐水洗涤,洗涤后再次进行离心,5500rpm,10min,得到无菌纯水悬浮菌体;S12 respectively take 4 ml of the culture liquid in each of the medium and centrifuge, 5500rpm, 10min, after the centrifugation, the cells are washed with sterile physiological saline with pH 6.8, and centrifuged again after washing, 5500rpm, 10min, to obtain sterile pure water suspension bacteria;
S13将400uL的所述无菌纯水悬浮菌体,沸水浴10min,10000rpm离心15min,收集上清液。S13 Suspend the bacterial cells in 400 uL of the sterile pure water, take a boiling water bath for 10 minutes, centrifuge at 10,000 rpm for 15 minutes, and collect the supernatant.
S2提取所述待测样品中的DNA和RNA,并将所述RNA逆转处理,得到cRNA,再将所述cRNA和所述DNA混合后进行多重荧光PCR扩散,得到荧光样品;S2 extracts the DNA and RNA in the sample to be tested, and reverses the RNA to obtain cRNA, and then mixes the cRNA and the DNA and performs multiple fluorescence PCR diffusion to obtain a fluorescent sample;
具体的,所述PCR扩增的反应条件为94℃预变性3min,94℃变性10S,55℃退火30S,72℃延伸90S,整个体系做28个循环,72℃后延伸5min,所述PCR扩增反应体系为:2×TaqPCR mix 10μL,DDH2O 9μL,上游引物F1 0.4μL,下游引物R1 0.4μL和样本模板0.2μL,漩涡混匀后闪离5s,置于PCR核酸扩增仪上反应。Specifically, the reaction conditions of the PCR amplification are as follows: pre-denaturation at 94°C for 3 min, denaturation at 94°C for 10S, annealing at 55°C for 30S, extension at 72°C for 90S, the whole system is performed for 28 cycles, and extension at 72°C for 5 min. The amplification reaction system is: 2×TaqPCR
具体方式:Specific way:
S21提取所述待测样品中的DNA和RNA,往提取到的所述RNA加热入逆转录反应液,所述RNA与所述逆转录反应液中的逆转录酶混合,得到cRNA;S21 extracts DNA and RNA in the test sample, heats the extracted RNA into a reverse transcription reaction solution, and mixes the RNA with the reverse transcriptase in the reverse transcription reaction solution to obtain cRNA;
S22将所述DNA和所述cRNA分别与混合酶混合,并对混合的所述DNA和所述cRNA进行多重荧光PCR扩散,得到所述荧光样品。S22 The DNA and the cRNA are mixed with a mixed enzyme, respectively, and the mixed DNA and the cRNA are subjected to multiplex fluorescence PCR diffusion to obtain the fluorescent sample.
S3通过荧光PCR扩增仪检测所述荧光样品,并显示的ct值判定检测结果。S3 detects the fluorescent sample by a fluorescent PCR amplifier, and the displayed ct value determines the detection result.
具体的,利用特异性引物和探针进行PCR反应,突变由FAM/ROX/CY5信号指示,内控由VIC信号指示,通过计算△ct值的大小进行判断,反应管的△ct值≤cut off值时,则样本为该反应管对应信号突变阳性,反之则为阴性或低于试剂盒的检测下线。△ct值=ct值突变位点-ct值内控。Specifically, specific primers and probes are used for PCR reaction, the mutation is indicated by the FAM/ROX/CY5 signal, and the internal control is indicated by the VIC signal. The Δct value of the reaction tube is judged by calculating the Δct value ≤ cut off value. When the sample is positive for the corresponding signal mutation of the reaction tube, it is negative or lower than the detection limit of the kit. Δct value = ct value mutation site - ct value internal control.
进一步的,所述荧光PCR扩增仪包括壳体1、扩增仪本体3、调温板4和放置组件,所述扩增仪本体3与所述壳体1固定连接,且位于所述壳体1内,所述调温板4设置于所述壳体1内,所述放置组件设置于所述调温板4远离所述扩增仪本体3一侧;所述放置组件包括放置板5、顶杆、固定杆和滑块,所述顶杆设置于所述壳体1靠近所述扩增仪本体3一侧,所述放置板5与所述壳体1滑动连接,且位于所述壳体1内,所述壳体1具有卡槽2,所述放置板5具有滑槽6,所述固定杆设置于所述滑槽6内,所述滑块与所述固定杆固定连接,并贯穿所述放置板5;所述固定杆包括滑杆7和第一弹簧8,所述滑杆7与所述放置板5滑动连接,且位于所述滑槽6内,所述第一弹簧8与所述滑杆7固定连接,并与所述放置板5固定连接,且位于所述滑杆7和所述放置板5之间。Further, the fluorescent PCR amplification instrument includes a
在本实施方式中,所述壳体1对所述扩增仪本体3、所述调温板4和所述放置组件提供安装条件,所述扩增仪本体3利用聚合酶链反应技术对所述DNA和所述cRNA进行扩增,所述调温板4连接冷却液源和热水源,对装有所述DNA和所述cRNA的试管进行加热和冷却,所述放置板5用于放置装有所述DNA和所述cRNA的试管,可同时放置多个试管进行检测,往所述壳体1内放置试管时,将试管放入所述放置板5内,检测员利用手部向中间拉动所述滑块,所述滑块滑动将所述固定杆收入所述放置板5内,检测员再并将所述放置板5放入所述壳体1内,松开所述滑块并下压所述放置板5,使所述放置板5在所述壳体1内滑动挤压所述顶杆,待所述滑槽6和所述卡槽2处于同一水平面时,所述第一弹簧8推动所述滑杆7滑出所述滑槽6,所述滑杆7插入所述卡槽2内,从而将所述放置板5固定,从所述壳体1内取出试管时,检测员再次向中间滑动所述滑块,所述滑块滑动使得所述滑杆7缩回所述滑槽6,将所述滑杆7与所述壳体1分开,所述顶杆复位将所述放置板5顶起,便于检测员将所述放置板5从所述壳体1内取出。In this embodiment, the
进一步的,所述滑块包括滑块本体9和拉杆10,所述滑块本体9与所述滑杆7固定连接,且贯穿所述放置板5,所述拉杆10与所述滑块本体9固定连接,且位于所述滑块本体9一侧。Further, the slider includes a
在本实施方式中,所述拉杆10的设置,便于检测员滑动所述滑块本体9,所述滑块本体9滑动控制所述滑杆7的滑动。In this embodiment, the setting of the
进一步的,所述顶杆包括伸缩杆11和第二弹簧12,所述伸缩杆11与所述壳体1固定连接,且位于靠近所述扩增仪本体3一侧,所述第二弹簧12套设于所述伸缩杆11上。Further, the top rod includes a
在本实施方式中,所述放置板5下压时,所述放置板5推动所述伸缩杆11,使得所述伸缩杆11和所述第二弹簧12压缩,取出试管时,所述滑杆7与所述壳体1分开,所述第二弹簧12复位带动所述伸缩杆11伸长,从而将所述放置板5顶起。In this embodiment, when the placing
以上所揭露的仅为本发明一种较佳实施例而已,当然不能以此来限定本发明之权利范围,本领域普通技术人员可以理解实现上述实施例的全部或部分流程,并依本发明权利要求所作的等同变化,仍属于发明所涵盖的范围。The above disclosure is only a preferred embodiment of the present invention, and of course, it cannot limit the scope of rights of the present invention. Those of ordinary skill in the art can understand that all or part of the process for realizing the above-mentioned embodiment can be realized according to the rights of the present invention. The equivalent changes required to be made still belong to the scope covered by the invention.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210854682.7A CN115198006A (en) | 2022-07-18 | 2022-07-18 | An XNA molecular clamp-multiplex fluorescent PCR method for gene mutation detection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210854682.7A CN115198006A (en) | 2022-07-18 | 2022-07-18 | An XNA molecular clamp-multiplex fluorescent PCR method for gene mutation detection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115198006A true CN115198006A (en) | 2022-10-18 |
Family
ID=83582480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210854682.7A Pending CN115198006A (en) | 2022-07-18 | 2022-07-18 | An XNA molecular clamp-multiplex fluorescent PCR method for gene mutation detection |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115198006A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109996891A (en) * | 2017-01-05 | 2019-07-09 | 南京帝基生物科技有限公司 | Methods for early detection of colon cancer and/or colon cancer precursor cells and for monitoring colon cancer recurrence |
| CN111235272A (en) * | 2020-01-10 | 2020-06-05 | 厦门艾德生物医药科技股份有限公司 | Composition for one-time detection of lung cancer multiple gene mutation and application thereof |
| CN214781781U (en) * | 2021-06-02 | 2021-11-19 | 天津海关动植物与食品检测中心 | PCR augmentor |
| CN214881408U (en) * | 2021-03-31 | 2021-11-26 | 河南省依斯特检测技术有限公司 | PCR amplification instrument with adjustable sample rack |
| CN215250734U (en) * | 2021-02-26 | 2021-12-21 | 上海完形健康管理咨询有限公司 | MicroRNA quantitative determination kit |
-
2022
- 2022-07-18 CN CN202210854682.7A patent/CN115198006A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109996891A (en) * | 2017-01-05 | 2019-07-09 | 南京帝基生物科技有限公司 | Methods for early detection of colon cancer and/or colon cancer precursor cells and for monitoring colon cancer recurrence |
| CN111235272A (en) * | 2020-01-10 | 2020-06-05 | 厦门艾德生物医药科技股份有限公司 | Composition for one-time detection of lung cancer multiple gene mutation and application thereof |
| CN215250734U (en) * | 2021-02-26 | 2021-12-21 | 上海完形健康管理咨询有限公司 | MicroRNA quantitative determination kit |
| CN214881408U (en) * | 2021-03-31 | 2021-11-26 | 河南省依斯特检测技术有限公司 | PCR amplification instrument with adjustable sample rack |
| CN214781781U (en) * | 2021-06-02 | 2021-11-19 | 天津海关动植物与食品检测中心 | PCR augmentor |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110229908A (en) | Primer, probe and kit for early detection change gene methylation level in lung cancer | |
| CN118291632A (en) | Primer probe composition for early screening of bladder cancer, kit and application | |
| CN112609002B (en) | Peripheral blood miRNA colon cancer diagnosis marker combination and detection kit thereof | |
| CN113652490A (en) | Primer probe combination and kit for early screening and/or prognosis monitoring of bladder cancer | |
| CN114959030B (en) | Application of reagent for detecting HCG9 gene methylation in preparation of product for diagnosing bladder cancer | |
| CN113621704B (en) | Reagent and kit for detecting and diagnosing liver cancer | |
| CN110484625A (en) | For detecting primer combination of probe object, kit and the detection method of PRKY gene methylation | |
| CN115198006A (en) | An XNA molecular clamp-multiplex fluorescent PCR method for gene mutation detection | |
| CN108796078B (en) | Primer and probe set for diagnosing, detecting or screening digestive tract cancer | |
| CN118834956A (en) | Primer and probe combination, kit and use thereof in detecting EMX1 and CHFR gene methylation | |
| CN117248021A (en) | Nucleic acid combination, kit and application for detecting urothelial cancer or precancerous lesions | |
| CN113862370B (en) | Primer, probe and kit for screening liver cancer and application of kit | |
| CN115927610B (en) | Application of reagents for detecting methylation levels of target regions in the FOXO6 gene in the preparation of bladder cancer diagnostic products | |
| CN118147298A (en) | Application of reagent for detecting methylation level in preparation of head and neck squamous cell carcinoma diagnostic product | |
| CN116716408A (en) | DNA methylation composition for detecting benign and malignant lung nodules, kit and application | |
| CN115851941A (en) | Marker, nucleic acid product and kit for screening esophageal cancer and application of marker and kit | |
| CN116676405A (en) | Primer group for detecting nocardia bacteria and application thereof | |
| CN102399858A (en) | DNA point mutation detection method based on fluorescence quenching relief | |
| CN116103411A (en) | Primer probe composition and kit for detecting helicobacter pylori drug-resistant gene mutation in sample | |
| WO2024036785A1 (en) | Dna methylation marker combination for early screening of gastric cancer and kit | |
| CN116004831A (en) | Reagent for diagnosing or assisting in diagnosing bladder cancer and detection kit | |
| CN107177688A (en) | The kit of the deaf susceptibility gene mutation of detection and its application | |
| CN113684279A (en) | Primer group, kit and detection method for diagnosing osteosarcoma | |
| CN114381519A (en) | Serum miRNA marker combination for breast cancer auxiliary diagnosis and detection kit thereof | |
| CN116162707B (en) | New application of reagent for detecting methylation level of target region in CYTH gene or/and SIX3 gene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |